Editorial

You have full text access to this OnlineOpen article

Is high-dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?†

  1. K. Thomas Robbins M.D.‡,*

Article first published online: 4 JAN 2005

DOI: 10.1002/cncr.20807

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 447–450, 1 February 2005

Additional Information

How to Cite

Robbins, K. T. (2005), Is high-dose intensity intraarterial cisplatin chemoradiotherapy for head and neck carcinoma feasible?. Cancer, 103: 447–450. doi: 10.1002/cncr.20807

Author Information

  1. Division of Otolaryngology, Southern Illinois University School of Medicine, Springfield, Illinois

  1. ‡

    Fax: (217) 545-7512

*Division of Otolaryngology, Southern Illinois University School of Medicine, 301 No. Eighth Street, P.O. Box 19662, Springfield, IL 62794-9662

  1. †

    See referenced original article on pages 559–68, this issue.

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 4 JAN 2005
  3. Manuscript Accepted: 14 OCT 2004
  4. Manuscript Received: 5 OCT 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (53K)

The author outlines his personal experience treating hundreds of patients with head and neck carcinoma using combined high-dose intraarterial cisplatin chemotherapy and concomitant, radiation therapy, and he also highlights the published experience of other investigators, all of whom concluded that the high-dose intensity approach is feasible and highly efficacious. This differs from the results reported in this issue by a group of investigators from the Mayo Clinic.

See referenced original article on pages 559–68, this issue.

View Full Article (HTML) Get PDF (53K)